SJS Investment Consulting »

Protalix Biotherapeutics shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2026-06-30 $69 30 2.33

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultr Fix Inc Etf (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Eli Lilly & Co. (LLY)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Apple (AAPL)
American Centy Etf Tr Us Eqt Etf (AVUS)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Hormel Foods Corporation (HRL)
American Centy Etf Tr Avan Tota Eq Etf (AVTM)
Dimensional Etf Trust Global Real Est (DFGR)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Us Sustainabilty (DFSU)

View all positions for SJS Investment Consulting

Top funds holding Protalix Biotherapeutics

BlackRock
Renaissance Technologies
Geode Capital Management
State Street Corporation
Northern Trust
Vanguard Portfolio Management
Stratos Wealth Partners
Dimensional Fund Advisors
Goldman Sachs Group
Marshall Wace
Citadel Advisors
Susquehanna International
Morgan Stanley
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Bank of New York Mellon

View all funds holding Protalix Biotherapeutics